Showing results (1061-1070 of 1,132) with videos related to
Sort By:
Pageof 114
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 17, 2026
Trajectory timelines and treatment efficacy of 177Lu-PSMA-617 radioligand therapy for metastatic castration-resistant prostate cancer: Real-world data from 50 consecutive cases treated in a single Canadian centerFrédéric Pouliot, Michele Lodde, Marjorie Besançon, et al.Journal of Medicinal Chemistry|February 15, 2019
Design of N-Benzoxaborole Benzofuran GSK8175-Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV InhibitorPek Y Chong, J Brad Shotwell, John Miller, et al.Cancer|May 5, 2025
Cemiplimab monotherapy as first-line treatment of patients with brain metastases from advanced non-small cell lung cancer with programmed cell death-ligand 1 ≥50Saadettin Kilickap, Mustafa Özgüroğlu, Ahmet Sezer, et al.Clinical Genitourinary Cancer|June 23, 2021
Active Surveillance in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information SystemIgal Kushnir, Naveen S Basappa, Sunita Ghosh, et al.Current Oncology (Toronto, Ont.)|March 27, 2026
Outcomes and Predictors of Recurrence and Survival in Surgically Resected Localized Chromophobe Renal Cell Carcinoma: Results from the Canadian Kidney Cancer Information System (CKCis)Erica Arenovich, Rodney Breau, Ricardo Rendon, et al.Urologic Oncology|June 9, 2026
Comparison of partial nephrectomy to radical nephrectomy for non-metastatic cT2 renal tumors: Results from a Canadian Multi-Institutional CollaborativeRahul K Bansal, Raees Cassim, Ranjeeta Mallick, et al.Oncotarget|October 27, 2017
[10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer in vivoAna Carolina B M Martin, Angelina M Fuzer, Amanda B Becceneri, et al.The Lancet. Oncology|December 7, 2020
Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trialThomas Powles, Elizabeth R Plimack, Denis Soulières, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 4, 2020
A prospective, multisite study analyzing the percentage of urological cases that can be completely managed by telemedicineBruno Turcotte, Sophie Paquet, Anne-Sophie Blais, et al.Molecular Cancer Therapeutics|July 24, 2023
First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and LymphomaErika P Hamilton, Judy S Wang, Amit M Oza, et al.Pageof 114